Triethylamine → HCID 71657549, compound
Reaction equation
[O:1]=[C:2]1[NH:7][CH2:6][CH2:5][N:4]2[N:8]=[C:9](C(O)=O)[CH:10]=[C:3]12.C1(P(N=[N+]=[N-])(C2C=CC=CC=2)=[O:21])C=CC=CC=1.CC[N:33]([CH2:36]C)CC.[F:38][C:39]1[CH:47]=[C:46]2[C:42]([CH2:43][CH2:44][N:45]2[CH:48]2[CH2:53][CH2:52][NH:51][CH2:50][CH2:49]2)=[CH:41][CH:40]=1>C1COCC1>[F:38][C:39]1[CH:47]=[C:46]2[C:42]([CH2:43][CH2:44][N:45]2[CH:48]2[CH2:53][CH2:52][N:51]([C:36]([NH:33][C:9]3[CH:10]=[C:3]4[C:2](=[O:1])[NH:7][CH2:6][CH2:5][N:4]4[N:8]=3)=[O:21])[CH2:50][CH2:49]2)=[CH:41][CH:40]=1Participants
6
Reactant 4
Product 1
Reagents, catalysts & solvents 1
Procedure
To a suspension of 4,5,6,7-tetrahydro-4-oxo-pyrazolo[1,5-a]pyrazine-2-carboxylic acid (181 mg, 1.0 mmol) in THF (15 mL) was added diphenylphosphoryl azide (0.25 mL, 1.0 mmol) and Et3N (0.28 mL. 2.0 mmol). The resulting mixture was heated to reflux for 6 h and cooled to room temperature. Then 6-fluoro-1-(piperidin-4-yl)indoline (88 mg, 0.4 mmol) and Et3N (0.14 mL, 1.0 mmol) were added sequentially. The resulting mixture was stirred at room temperature for 24 h and concentrated. The resulting residue was purified by chromatography using EtOAc, then 2-5% MeOH/EtOAc as the eluent to yield 4-(6-fluoroindolin-1-yl)-N-(4-oxo-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrazin-2-yl)piperidine-1-carboxamide.
Workup
- temperatureThe resulting mixture was heated
- temperatureto reflux for 6 h
- concentrationconcentrated
- customThe resulting residue was purified by chromatography
Sources & evidence
- ORD record
- ord-ca856f801a4e40709bd111546ae06473
- Source dataset
- uspto-grants-2016_01
- Patent number
- US09238658B2
Reaction notes
Loading…